Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
ITCI holding history
Intra-Cellular Therapies, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ITCI overviewAll 13F holders of ITCIFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −516,719−100.0% | Sold out | Holders |
| Q4 2024 | 516,719 | $43.2M | 0.1% | −112,120−17.8% | Reduced | Holders |
| Q3 2024 | 628,839 | $46.0M | 0.1% | −4,619−0.7% | Reduced | Holders |
| Q2 2024 | 633,458 | $43.4M | 0.1% | +160,771+34.0% | Added | Holders |
| Q1 2024 | 472,687 | $32.7M | 0.1% | −300,280−38.8% | Reduced | Holders |
| Q4 2023 | 772,967 | $55.4M | 0.2% | +120,937+18.5% | Added | Holders |
| Q3 2023 | 652,030 | $34.0M | 0.1% | −640,738−49.6% | Reduced | Holders |
| Q2 2023 | 1,292,768 | $81.9M | 0.3% | +588,837+83.6% | Added | Holders |
| Q1 2023 | 703,931 | $38.1M | 0.1% | −183,442−20.7% | Reduced | Holders |
| Q4 2022 | 887,373 | $47.0M | 0.2% | −1,131,313−56.0% | Reduced | Holders |
| Q3 2022 | 2,018,686 | $93.9M | 0.3% | +167,737+9.1% | Added | Holders |
| Q2 2022 | 1,850,949 | $105.7M | 0.4% | −130,407−6.6% | Reduced | Holders |
| Q1 2022 | 1,981,356 | $121.2M | 0.3% | −149,464−7.0% | Reduced | Holders |
| Q4 2021 | 2,130,820 | $111.5M | 0.3% | +42,786+2.0% | Added | Holders |
| Q3 2021 | 2,088,034 | $77.8M | 0.2% | −57,554−2.7% | Reduced | Holders |
| Q2 2021 | 2,145,588 | $87.6M | 0.2% | +23,448+1.1% | Added | Holders |
| Q1 2021 | 2,122,140 | $72.0M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.